Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

© Springer International Publishing Switzerland 2017. Glucocorticoids have a diverse array of functions affecting almost all tissues in the body. While circulating cortisol levels are under the control of the hypothalamo- pituitary-adrenal axis, within individual organs and tissues, a series of enzymes is able to metabolize, either inactivating or reactivating glucocorticoids to control their availability to bind and activate the glucocorticoid receptor. The most studied of these enzymes are the 11β-hydroxysteroid dehydrogenases (type 1 and type 2) and the A-ring reductases (5α-reductase type 1 and 2 and 5β-reductase). 11β-Hydroxysteroid dehydrogenase type 1 regenerates active glucocorticoid (cortisol) from inactive cortisone and thus amplifi es local glucocorticoid action. In contrast, 11β-hydroxysteroid dehydrogenase type 2 and the A-ring reductases clear and inactivate glucocorticoids. All have tissue-specifi c patterns of expression and regulation and have been implicated in the pathogenesis of many diseases that are discussed as part of this chapter. In addition, 11β-hydroxysteroid dehydrogenases type 1 represents a novel therapeutic target and selective inhibitors that decease tissuespecifi c glucocorticoid levels have reached phase II clinical trials. The prereceptor regulation of glucocorticoid action is therefore not only of fundamental physiological and pathological importance, but continues to represent an area of intense scientifi c and therapeutic interest.

Original publication

DOI

10.1007/978-3-319-45950-9_14

Type

Chapter

Book title

The Hypothalamic-Pituitary-Adrenal Axis in Health and Disease: Cushing's Syndrome and Beyond

Publication Date

01/01/2016

Pages

271 - 301